[1]赵立宇,姜茂华,杨芳,等.糖尿病性视网膜病变患者常规全视网膜光凝后黄斑中心凹下脉络膜厚度变化的荟萃分析[J].眼科新进展,2022,42(2):136-141.[doi:10.13389/j.cnki.rao.2022.0028]
　ZHAO Liyu,JIANG Maohua,YANG Fang,et al.A meta-analysis of changes in the subfoveal choroidal thickness in diabetic retinopathy patients after conventional panretinal photocoagulation[J].Recent Advances in Ophthalmology,2022,42(2):136-141.[doi:10.13389/j.cnki.rao.2022.0028]
点击复制

糖尿病性视网膜病变患者常规全视网膜光凝后黄斑中心凹下脉络膜厚度变化的荟萃分析/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
42卷
期数:
2022年2期
页码:
136-141
栏目:
应用研究
出版日期:
2022-02-05

文章信息/Info

Title:
A meta-analysis of changes in the subfoveal choroidal thickness in diabetic retinopathy patients after conventional panretinal photocoagulation
作者:
赵立宇; 姜茂华; 杨芳; 吴昌凡; 张鹏飞
241000　安徽省芜湖市，华东师范大学附属芜湖医院（赵立宇，姜茂华，杨芳），241000　安徽省芜湖市，皖南医学院第一附属医院（吴昌凡，张鹏飞）
Author(s):
ZHAO Liyu1; JIANG Maohua1; YANG Fang1; WU Changfan2; ZHANG Pengfei2
1.Wuhu Hospital Affiliated to East China Normal University,Wuhu 241000,Anhui Province,China
2.The First Affiliated Hospital of Wannan Medical College,Wuhu 241000,Anhui Province,China
关键词:
糖尿病性视网膜病变; 黄斑中心凹下脉络膜厚度; 全视网膜光凝; 荟萃分析; 光学相干断层扫描
Keywords:
meta-analysis;  diabetic retinopathy;  subfoveal choroidal thickness;  panretinal photocoagulation;  optical coherence tomography
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2022.0028
文献标志码:
A
摘要:
目的　通过荟萃分析系统评价糖尿病性视网膜病变（DR）患者在常规全视网膜光凝（PRP）后黄斑中心凹下脉络膜厚度（SFCT）的变化。方法　检索PubMed、EMBASE、Web of Science及Cochrane Library英文数据库和万方数据知识服务平台、维普中文期刊服务平台及中国知网中文数据库，搜集行PRP术后不同时间段DR患者SFCT的相关文献，由两位评价者独立进行文献检索、筛选、质量评价及数据提取，采用合并的加权平均差（WMD）和95%置信区间（CI）作为统计量，各文献研究间的异质性采用Q和I2检验，如P<0.05或I2>50％则认为异质性较大，采用敏感性分析剔除发表偏倚差异较大的研究或存在高偏倚风险的研究,而后检测合并结果的稳定性,如剔除后异质性仍不显著降低,则采用随机效应模型进行分析。结果　初步检索各数据库最初获得文献141篇，根据纳入与排除标准，最终将11篇文献共计401眼纳入研究。考虑到纳入文献样本量较少，无论I2如何，均首选随机效应模型。经随机效应模型分析，PRP术后1周，合并的WMD显示SFCT较基线时显著增加（WMD=-18.012，95％CI为31.905～4.118，P=0.011）；PRP术后1个月，合并的WMD显示SFCT与基线无显著差异（WMD=10.818，95％CI为-0.993～22.630，P=0.073），PRP术后3个月和6个月，合并的WMD均显示SFCT较基线时显著下降（WMD=15.973，95％CI为5.610～26.336，P=0.003；WMD=18.249，95％CI为0.560～35.939，P=0.043）。结论　DR患者行PRP术后，SFCT在早期会增高，并会随着时间推移降低，到术后3个月时会显著降低至基线水平。
Abstract:
Objective　To evaluate the changes in the subfoveal choroidal thickness (SFCT) in diabetic retinopathy (DR) patients after conventional panretinal photocoagulation (PRP) using a meta-analysis system.Methods　By searching PubMed, EMBASE, Web of Science and Cochrane Library English databases, Wanfang Data Knowledge Service Platform, VIP Chinese Journal Service Platform, and CNKI Chinese Database, two researchers collected literature studying the SFCT of DR patients at different times post PRP. The two researchers independently performed paper search, screening, quality evaluation, and data extraction, and used pooled weighted mean differences (WMD) and 95% confidence interval (CI) as statistical data. Q and I2 tests were used to evaluate the heterogeneity among different studies, with P<0.05 or I2>50% indicating large heterogeneity. Sensitivity analysis was used to exclude studies with large bias or with a high risk of bias, and then the stability of the combined results was checked. If the exclusion did not significantly reduce heterogeneity, the random effects model was used for analysis.Results　A preliminary search in the above databases initially obtained 141 relevant studies. After screening based on inclusion and exclusion criteria, 11 studies that investigated a total of 401 eyes were eventually included in the meta-analysis. Considering that the sample size of the included studies was relatively small, the random effects model was preferred regardless of I2 value. As shown by the random effects model analysis, one week after PRP, the combined WMD showed a significant increase in SFCT (WMD=-18.012; 95%CI:［31.905, 4.118］; P=0.011). One month after PRP, the combined WMD showed that the SFCT was not significantly different from the baseline (WMD=10.818; 95%CI:［-0.993, 22.630］, P=0.073). Three and six months after PRP, the combined WMD showed a significant decrease in SFCT (three months:WMD=15.973; 95%CI:［5.610, 26.336］, P=0.003. Six months:WMD=18.249; 95%CI:［0.560, 35.939］, P=0.043).Conclusion　After PRP, DR patients will have increased SFCT first, which then gradually decreases over time and becomes significantly lower than the baseline after three months.

参考文献/References:

［1］　RUTA L M,MAGLIANO D J,LEMESURIER R,TAYLOR H R,ZIMMET P Z,SHAW J E.Prevalence of diabetic retinopathy in type 2 diabetes in developing and developed countries［J］.Diabet Med,2013,30(4):387-398.
［2］　UNSAL E,ELTUTAR K,ZIRTILO GˇLU S,DINER N,OZDO GˇAN E S,GNGEL H.Choroidal thickness in patients with diabetic retinopathy［J］.Clin Ophthalmol,2014,8(8):637-642.
［3］　KIM J T,LEE D H,JOE S G,KIM J G,YOON Y H.Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients［J］.Invest Ophthalmol Vis Sci,2013,54(5):3378-3384.
［4］　HUA R,LIU L,WANG X,CHEN L.Imaging evidence of diabetic choroidopathy in vivo:angiographic pathoanatomy and choroidal-enhanced depth imaging［J］.PLoS One,2013,8(12):e83494.
［5］　CAMPOS A,CAMPOS E J,MARTINS J,AMBRSIO A F,SILVA R.Viewing the choroid:where we stand,challenges and contradictions in diabetic retinopathy and diabetic macular oedema［J］.Acta Ophthalmol,2017,95(5):446-459.
［6］　PRETI R C,MUTTI A,FERRAZ D,ZACHARIAS L C,NAKASHIMA Y,TAKAHASHI W Y,et al.The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy［J］.Clinics (Sao Paulo),2017,72(2):81-86.
［7］　KIM J S,JY K,KIM K T,CHAE J B,KIM J H,KIM D Y.Near reading speed changes after panretinal photocoagulation in diabetic retinopathy patients:a prospective study using an iPad application for the measurement of reading speed［J］.Graefes Arch Clin Exp Ophthalmol,2019,257(12):2631-2638.
［8］　KINOSHITA T,IMAIZUMI H,SHIMIZU M,MORI J,HATANAKA A,AOKI S,et al.Systemic and ocular determinants of choroidal structures on optical coherence tomography of eyes with diabetes and diabetic retinopathy［J］.Sci Rep,2019,9(1):16228.
［9］　KANG H M,LEE N E,CHOI J H,KOH H J,LEE S C.Significant reduction of both peripapillary and subfoveal choroidal thickness after panretinal photocoagulation in patients with type 2 diabetes［J］.Retina,2018,38(10):1905-1912.
［10］　OKAMOTO M,YAMASHITA M,OGATA N.Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema［J］.Graefes Arch Clin Exp Ophthalmol,2018,256(5):885-892.
［11］　KIM J T,PARK N.Changes in choroidal vascular parameters following pan-retinal photocoagulation using swept-source optical coherence tomography［J］.Graefes Arch Clin Exp Ophthalmol,2020,258(1):39-47.
［12］　PARK N,LEE I G,KIM J T.Changes in choroidal thickness in advanced diabetic retinopathy treated with pan-retinal photocoagulation using a pattern scanning laser versus a conventional laser［J］.BMC Ophthalmol,2020,20(1):226.
［13］　OHARA Z,TABUCHI H,NAKAKURA S,YOSHIZUMI Y,SUMINO H,MAEDA Y,et al.Changes in choroidal thickness in patients with diabetic retinopathy［J］.Int Ophthalmol,2018,38(1):279-286.
［14］　MIKOSHIBA Y,IWASE T,UENO Y,YAMAMOTO K,RA E,TERASAKI H.A randomized clinical trial evaluating choroidal blood flow and morphology after conventional and pattern scan laser panretinal photocoagulation［J］.Sci Rep,2018,8(1):14128.
［15］　王乐丹,林咸平,崔钢峰.广泛视网膜光凝术对糖尿病性视网膜病变患者黄斑区脉络膜厚度的影响［J］.中华眼外伤职业眼病杂志,2017,39(9):706-709.
WANG L D,LIN X P,CUI G F.Effect of panretinal photocoagulation on choroidal thickness of macular in patients with diabetic retinopathy［J］.Chin J Ocul Traum Occupat Eye Dis,2017,39(9):706-709.
［16］　OKAMOTO M,MATSUURA T,OGATA N.Effects of panretinal photocoagulation on choroidal thickness and choroidal blood flow in patients with severe nonproliferative diabetic retinopathy［J］.Retina,2016,36(4):805-811.
［17］　ROOHIPOOR R,SHARIFIAN E,GHASSEMI F,RIAZI-ESFAHANI M,KARKHANEH R,FARD M A,et al.Choroidal thickness changes in proliferative diabetic retinopathy treated with panretinal photocoagulation versus panretinal photocoagulation with intravitreal bevacizumab［J］.Retina,2016,36(10):1997-2005.
［18］　ZHANG Z,MENG X,WU Z,ZOU W,ZHANG J,ZHU D,et al.Changes in choroidal thickness after panretinal photocoagulation for diabetic retinopathy:a 12-week longitudinal study［J］.Invest Ophthalmol Vis Sci,2015,56(4):2631-2638.
［19］　景作乾,柳力敏,陈蕾.应用EDI-SD OCT观察全视网膜光凝对糖尿病视网膜病变黄斑区脉络膜厚度的影响［J］.眼科新进展,2015,35(9):839-843.
JING Z Q,LIU L M,CHEN L.Effects observation of panretinal photocoagulation on macular choroidal thickness of diabetic retinopathy by EDI-SD OCT［J］.Rec Adv Ophthalmol,2015,35(9):839-843.
［20］　徐静娴,张贤亮,石壮,臧博,周文凯,张劲松.糖尿病视网膜病变激光光凝术后黄斑区脉络膜厚度变化的观察［J］.中国实用眼科杂志,2015,33(6):598-602.
XU J X,ZHANG X L,SHI Z,ZANG B,ZHOU W K,ZHANG J S.The changes in macular choroidal thickness of patients with diabetic retinopathy after panretinal photocoagulation (PRP)［J］.Chin J Pract Ophthalmol,2015,33(6):598-602.
［21］　LEE S H,KIM J,CHUNG H,KIM H C.Changes of choroidal thickness after treatment for diabetic retinopathy［J］.Curr Eye Res,2014,39(7):736-744.
［22］　CHO G E,CHO H Y,KIM Y T.Change in subfoveal choroidal thickness after Argon laser panretinal photocoagulation［J］.Int J Ophthalmol,2013,6(4):505-509.
［23］　BEGG C B,MAZUMDAR M.Operating characteristics of a rank correlation test for publication bias［J］.Biometrics,1994,50:1088-1101.
［24］　EGGER M,DAVEY SMITH G,SCHNEIDER M,MINDER C.Bias in meta-analysis detected by a simple,graphical test［J］.BMJ,1997,315(719):629-634.
［25］　NONAKA A,KIRYU J,TSUJIKAWA A,YAMASHIRO K,NISHIJIMA K,KAMIZURU H,et al.Inflammatory response after scatter laser photocoagulation in nonphotocoagulated retina［J］.Invest Ophthalmol Vis Sci,2002,43(4):1204-1209.
［26］　YUKI T,KIMURA Y,NANBU S,KISHI S,SHIMIZU K.Ciliary body and choroidal detachment after laser photocoagulation for diabetic retinopathy.A high-frequency ultrasound study［J］.Ophthalmology,1997,104(97):30143-30149.
［27］　GENTILE R C,STEGMAN Z,LIEBMANN J M,DAYAN A R,TELLO C,WALSH J B,et al.Risk factors for ciliochoroidal effusion after panretinal photocoagulation［J］.Ophthalmology,1996,103(5):827-832.
［28］　AIELLO L P,AVERY R L,ARRIGG P G,KEYT B A,JAMPEL H D,SHAH S T,et al.Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders［J］.N Engl J Med,1994,331(22):1480-1487.
［29］　TAKAHASHI A,NAGAOKA T,SATO E,YOSHIDA A.Effect of panretinal photocoagulation on choroidal circulation in the foveal region in patients with severe diabetic retinopathy［J］.Br J Ophthalmol,2008,92(10):1369-1373.
［30］　ARNARSSON A,STEFNSSON E.Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion［J］.Invest Ophthalmol Vis Sci,2000,41(3):877-879.

相似文献/References:

[1]张 洁 孟小妹 张亦农.重度非增殖性与增殖性糖尿病性视网膜病变多焦视网膜电图一阶函数核的特征分析[J].眼科新进展,2008,28(9):000.
[2]陈娟,吕红彬. 抗VEGF药物在糖尿病性视网膜病变治疗中的应用[J].眼科新进展,2014,34(4):397.[doi:10.13389/j.cnki.rao.2014.0110]
[3]李婷婷,胡健艳,吴强.靶向G蛋白偶联受体91的小发夹RNA慢病毒载体的构建及功能初步检测[J].眼科新进展,2014,34(8):705.[doi:10.13389/j.cnki.rao.2014.0193]
　Li Ting-Ting,HU Jian-Yan,WU Qiang.Construction and identification of shRNA lentiviral vector of G protein-coupled receptor 91[J].Recent Advances in Ophthalmology,2014,34(2):705.[doi:10.13389/j.cnki.rao.2014.0193]
[4]陈明,刘志谦,段志辉,等.玻璃体切割联合保留前囊膜的晶状体切除治疗糖尿病性视网膜病变[J].眼科新进展,2014,34(10):956.[doi:10.13389/j.cnki.rao.2014.0265]
[5]陈小红,王云鹏,陈梅珠. VEGF在糖尿病性视网膜病变发病机制中的作用及抗VEGF治疗新进展[J].眼科新进展,2015,35(7):692.[doi:10.13389/j.cnki.rao.2015.0190]
　CHEN Xiao-Hong,WANG Yun-Peng,CHEN Mei-Zhu. Role of VEGF in pathogenesis of diabetic retinopathy and anti-VEGF therapy[J].Recent Advances in Ophthalmology,2015,35(2):692.[doi:10.13389/j.cnki.rao.2015.0190]
[6]王媛,张金嵩,李秀娟.高度近视并发脉络膜新生血管患者黄斑中心凹下脉络膜厚度变化[J].眼科新进展,2015,35(10):949.[doi:10.13389/j.cnki.rao.2015.0258]
　WANG Yuan,ZHANG Jin-Song,LI Xiu-Juan.Changes of subfoveal choroidal thickness in high myopia with choroidal neovascularization[J].Recent Advances in Ophthalmology,2015,35(2):949.[doi:10.13389/j.cnki.rao.2015.0258]
[7]向小红,吕红彬.雌激素与糖尿病性视网膜病变的研究进展[J].眼科新进展,2017,37(5):496.[doi:10.13389/j.cnki.rao.2017.0126]
　XIANG Xiao-Hong,LV Hong-Bin.Recent advances in estrogen and diabetic retinopathy[J].Recent Advances in Ophthalmology,2017,37(2):496.[doi:10.13389/j.cnki.rao.2017.0126]
[8]张鹏飞,张杰,高荣玉,等.玻璃体内注射血管内皮生长因子（VEGF）抑制剂治疗糖尿病视网膜病变患者的疗效[J].眼科新进展,2018,38(10):977.[doi:10.13389/j.cnki.rao.2018.0231]
　ZHANG Peng-Fei,ZHANG Jie,GAO Rong-Yu,et al.The efficacy of intravitreal injection of vascular endothelial growth factor （VEGF） inhibitors in patients with diabetic retinopathy[J].Recent Advances in Ophthalmology,2018,38(2):977.[doi:10.13389/j.cnki.rao.2018.0231]
[9]许冬,李浩,周利晓,等.基于卷积神经网络UNet构建糖尿病性黄斑水肿自动识别模型[J].眼科新进展,2020,40(4):357.[doi:10.13389/j.cnki.rao.2020.0082]
　XU Dong,LI Hao,ZHOU Lixiao,et al.Model of automatic identification of diabetic macular edema via convolutional neural networks UNet[J].Recent Advances in Ophthalmology,2020,40(2):357.[doi:10.13389/j.cnki.rao.2020.0082]
[10]李莹莹,蔺晓慧.糖尿病性视网膜病变患者血清中脂肪细胞因子的表达及其影响因素分析[J].眼科新进展,2021,41(1):057.[doi:10.13389/j.cnki.rao.2021.0012]
　LI Yingying,LIN Xiaohui.Expression of adipocytokines in the serum of patients with diabetic retinopathy and its factors[J].Recent Advances in Ophthalmology,2021,41(2):057.[doi:10.13389/j.cnki.rao.2021.0012]

备注/Memo

备注/Memo:
国家自然科学基金项目(编号：81700867)；安徽省自然科学基金项目(编号：1808085MH253)
更新日期/Last Update: 2022-02-05